Omnia Family Wealth LLC Has $317,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Omnia Family Wealth LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 45.7% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 603 shares of the healthcare conglomerate’s stock after buying an additional 189 shares during the period. Omnia Family Wealth LLC’s holdings in UnitedHealth Group were worth $317,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Bray Capital Advisors lifted its holdings in UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock valued at $4,848,000 after buying an additional 50 shares during the period. Asset Management One Co. Ltd. raised its holdings in UnitedHealth Group by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 479,578 shares of the healthcare conglomerate’s stock worth $241,798,000 after purchasing an additional 2,245 shares during the period. Warren Street Wealth Advisors LLC raised its holdings in UnitedHealth Group by 10.3% in the third quarter. Warren Street Wealth Advisors LLC now owns 783 shares of the healthcare conglomerate’s stock worth $395,000 after purchasing an additional 73 shares during the period. Blue Fin Capital Inc. raised its holdings in UnitedHealth Group by 1.6% in the third quarter. Blue Fin Capital Inc. now owns 14,861 shares of the healthcare conglomerate’s stock worth $7,493,000 after purchasing an additional 234 shares during the period. Finally, WestEnd Advisors LLC raised its holdings in UnitedHealth Group by 9.6% in the third quarter. WestEnd Advisors LLC now owns 72,726 shares of the healthcare conglomerate’s stock worth $36,668,000 after purchasing an additional 6,360 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded up $1.49 during trading hours on Friday, hitting $495.35. The company had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The firm has a market cap of $455.76 billion, a PE ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The firm has a 50-day moving average of $485.84 and a 200 day moving average of $514.14.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the prior year, the business posted $6.26 EPS. The business’s revenue was up 8.6% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. HSBC raised shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research report on Thursday, April 4th. Finally, Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.